Skip to main content

Keith Gottesdiener

Equibles does not estimate personal net worth.

About Keith Gottesdiener

Earlier roles on record: CEO and Board Member at Prime Medicine, Inc. (PRME) until May 18, 2025. Prime Medicine, Inc. reported in an 8-K filed May 19, 2025 that Keith Gottesdiener resigned as member of the Board of Directors, effective May 18, 2025. The same filing states: “Dr. Gottesdiener’s decision to resign from the Board was not the result of any disagreement with the Company on any matter relating to the operations, policies or practices of the Company.” Prime Medicine, Inc. reported in an 8-K filed May 19, 2025 that Keith Gottesdiener resigned as President, Chief Executive Officer and principal executive officer, effective May 18, 2025. The same filing states: “Dr. Gottesdiener’s decision to resign from the Board was not the result of any disagreement with the Company on any matter relating to the operations, policies or practices of the Company.” The proxy statement of Prime Medicine, Inc. reports total compensation of $2,207,770 for Keith Gottesdiener in fiscal 2025, including a base salary of $259,568. Disclosed compensation is on record for 5 fiscal years.

“On May 19, 2025, Prime Medicine, Inc. (the “Company”) announced that Keith Gottesdiener, M.D. had resigned as President, Chief Executive Officer and principal executive officer of the Company, and as a member of the Board of Directors of the Company (the “Board”), as well as from all other officer and director positions he held with the Company and any of its subsidiaries, in each case effective as of the end of day on May 18, 2025 (the “Resignation”).”
“Dr. Gottesdiener’s decision to resign from the Board was not the result of any disagreement with the Company on any matter relating to the operations, policies or practices of the Company.”
Prime Medicine, Inc. Form 8-K, filed May 19, 2025 · Read the filing
“On May 19, 2025, Prime Medicine, Inc. (the “Company”) announced that Keith Gottesdiener, M.D. had resigned as President, Chief Executive Officer and principal executive officer of the Company, and as a member of the Board of Directors of the Company (the “Board”), as well as from all other officer and director positions he held with the Company and any of its subsidiaries, in each case effective as of the end of day on May 18, 2025 (the “Resignation”).”
“Dr. Gottesdiener’s decision to resign from the Board was not the result of any disagreement with the Company on any matter relating to the operations, policies or practices of the Company.”
Prime Medicine, Inc. Form 8-K, filed May 19, 2025 · Read the filing

Affiliation history

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Prime Medicine, Inc. (PRME) $259,568 $2,207,770
2024 Prime Medicine, Inc. (PRME) $652,792 $2,245,617
2023 Prime Medicine, Inc. (PRME) $625,000 $5,403,071
2022 Prime Medicine, Inc. (PRME) $542,340 $924,044
2021 Prime Medicine, Inc. (PRME) $524,000 $2,939,433

Recent activity